NASDAQIndustrialsManufacturing - Tools & AccessoriesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Quarter ending 2027-01-04 | ||
| Revenue | — | 73.49M |
| EPS | — | 0.5 |
| Annual ending 2027-01-03 | ||
| Revenue | — | 293.48M |
| EPS | — | 2.56 |
Management figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Increase cash from operating activities to at least $3.48 million by Q1 2027 | Eastern Company is growing cash from operations, reaching $3.48 million by Q1 2027. | Broken | cash from operations falls below $3.11 million by 2027-Q1 | Cash from operations: $8.557M FY2026-Q2; GAAP. Published target: >= $3.48 million. The stored target says 2027-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 11, 20268,557,215 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jul 4, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextManagement stated increasing cash from operating activities as a priority in 4 quarters including 2025-Q2 through 2027-Q2. Cash from operations rose from $3.1 million in 2025-Q3 to $8.6 million in 2027-Q2, demonstrating improving operational cash flow. The trajectory is delivering on the stated priority. Delivery assessment Oct 24, 2026 |
Maintain EPS guidance at $0.11 for fiscal year 2026 | The company maintains EPS guidance at $0.11 for fiscal 2026. | Broken | EPS falls below $0.11 in FY26 | Diluted EPS: $0.94 per share FY2027-Q2; GAAP. Published target: EPS = $0.11. Target period is not explicitly aligned with this observation. Source published Aug 11, 20260.94 USD/share · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2027-Q2 · Period ending Jul 4, 2026 Source: company_financial_results. Reference: 3297737a-299b-4b89-9f21-31bc529c9897. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextEPS guidance around $0.11 was stated in 3 quarters including 2026-Q1 and 2027-Q2. Actual diluted EPS grew from $0.11 in 2026-Q1 to $0.94 in 2027-Q2, exceeding prior guidance levels. The trajectory shows improving earnings performance consistent with management's stated guidance and priorities. Delivery assessment Oct 24, 2026 |
Successful integration of Sungear and Crown Precision acquisitions | Recent acquisitions of Sungear and Crown Precision could strengthen its market position. | Intact | Acquisitions fail to contribute or cause operational disruption | Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 disclosures including 2026-Q2. The company acquired Sungear and Crown Precision for $7.85 million, adding a fourth operating platform focused on aerospace and defense. These acquired businesses generated approximately $22.8 million revenue trailing twelve months ended April 1, 2026. The acquisition aligns with strategic growth and portfolio expansion priorities and is delivering as planned. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 3, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
EML is a smaller-cap industrial company with an acquisition-led growth element, rather than a clearly established durable compounder. The multi-year view has support from stronger reported earnings and operating cash flow, while the current thesis state remains watch and confidence is medium.
The evidence labels EML cheap, but it also shows a 1.8 premium versus peers, with valuation divergence tied to a possible re-rating. No fragility gates are active, yet the evidence does not specify which growth or earnings expectations are already reflected in the valuation.
Recent results and execution are mixed: diluted EPS and cash from operations improved, while recent financial performance remains neutral and below the industry cohort. The Sungear and Crown Precision acquisition adds an aerospace and defense platform, though its status is mixed; elevated miss risk and a sector headwind remain near-term concerns.
The next earnings call is a key near-term test, since a guidance cut could lead to lower Street estimates. Over the multi-year view, execution on the acquired businesses and sustained improvement in earnings and operating cash flow matter; industrial bellwethers’ results could also signal whether sector support strengthens or fades.
EML’s multi-year thesis has evidence of improving execution, but weaker relative performance, sector pressure, and elevated earnings risk leave important questions unresolved. The evidence supports a watch-state assessment, not a settled thesis. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.